NCT00331981View on ClinicalTrials.gov

Amisulpride in Schizophrenic Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

February 29, 2004

Conditions
Schizophrenia
Interventions
DRUG

Amisulpride

Trial Locations (1)

Unknown

Sanofi-Aventis, Seoul

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00331981 - Amisulpride in Schizophrenic Patients | Biotech Hunter | Biotech Hunter